Skin Cancer News and Research

Latest Skin Cancer News and Research

Abbott's investigational anti-interleukin-12 fully human monoclonal antibody in Crohn's disease study

Results of a Phase II study of Abbott's ABT-874, a fully human anti-interleukin-12 (IL-12) monoclonal antibody, will appear tomorrow in the New England Journal of Medicine citing treatment with ABT-874 shows differences in response and remission in patients with active Crohn's disease compared to placebo, in one arm of the study.

10 Nov 2004

New study to determine whether natural tomato oil may reverse or delay progression of prostate cancer

Lycopene, an antioxidant commonly found in tomatoes and tomato-based products, is commonly perceived to reduce the risk of developing prostate cancer.

8 Nov 2004

Obesity could more than double an older woman's risk of acute myelogenous leukemia

A study from the University of Minnesota Cancer Center indicates that overweight and obesity could more than double an older woman's risk of acute myelogenous leukemia (AML), an often fatal cancer of the bone marrow and blood.

8 Nov 2004

Link between immune protein and longer survival in melanoma patients

Immune responses to prevent or delay the spread of melanoma, a deadly form of skin cancer, are more likely to prolong survival in patients if their immune cells carry a special kind of marker on the surface, according to a team of researchers at the University of Virginia Health System.

5 Nov 2004

STAT3 protein could lead to new ways to prevent skin cancer

Scientists at The University of Texas M. D. Anderson Cancer Center have identified a protein that serves as a master regulator of skin cancer - a finding that could lead to new ways to prevent skin cancer before it starts.

4 Nov 2004

Common antibacterial and antifungal ingredient used in tooth paste may protect against skin cancer

According to new studies, sanguinarine was shown to enhance production of proteins that induce cell death, or apoptosis, in cells damaged by ultraviolet-B (UVB) radiation.

21 Oct 2004

Cyclopamine, derived from the corn lily may treat and prevent basal cell carcinoma

Researchers at the University of Texas Medical Branch at Galveston (UTMB) have demonstrated in laboratory animals that a compound derived from a common plant can be used to treat and prevent the most widespread form of cancer in people

18 Oct 2004

Melanin is not only good for you, it also can be bad

Blondes and redheads not only are more susceptible to skin cancer, but the source of their skin and hair pigmentation, melanin, actually magnifies the damaging effects of ultraviolet (UV) rays, according to a study published online this week in the Proceedings of the National Academy of Sciences.

13 Oct 2004

Nanotechnology company pSivida granted European patent

Nanotechnology company pSivida has announced that its UK operating subsidiary pSiMedica Limited has been granted a further patent for BioSiliconTM.

13 Oct 2004

Wound healers cause skin disease

Dutch researcher Manon Franssen has shown that cells which heal the skin following an injury play an important role in the development of the skin disease psoriasis. In people with psoriasis, the skin peels much faster than normal so that it flakes and becomes inflamed.

11 Oct 2004

Half of all Australians still believe a tan is healthy

New research showing half of all Australians still believe a tan is healthy has added to cancer experts’ fears of a prolonged national skin cancer epidemic.

6 Oct 2004

Researchers are studying a vaccine that, in the future, could be the first to treat advanced malignant melanoma

Unlike traditional vaccines, cancer vaccines are not meant to be given to healthy people to prevent cancer. Rather, they are meant to be used in sick patients to strengthen their immune system to better fight the cancer.

4 Oct 2004

Skin cancer rates concern Australian health experts

Victorian Premier Steve Bracks joined The Cancer Council Victoria today to launch the 2004 SunSmart season. Releasing the latest skin cancer rates for Victoria, Professor David Hill, Director of the Cancer Council warned of the human and economic costs to all Victorians if skin cancer rates continue to increase.

30 Sep 2004

Prostate cancer treatment leads to declines in sexual and urinary function

Treatment for prostate cancer leads to significant five-year declines in sexual and urinary function, according to a new study. However, general and other specific health-related quality of life factors, such as bowel function, are not affected.

27 Sep 2004

University of Arizona spin-off investigates DNA damage to human skin

Niadyne, Inc., a Tucson-based spin-off biopharmaceutical company co-founded by two University of Arizona professors, has received a Small Business Innovation Research grant of nearly $750,000 to continue investigating the prevention of DNA damage to human skin

22 Sep 2004

Certain cancers might one day be cured without the use of toxic chemotherapy and radiation

The eradication of brain tumors in mice following treatment with a novel drug suggests that certain cancers might one day be cured without the use of toxic chemotherapy and radiation.

20 Sep 2004

Shade structures are not built effectively

Skin cancer causes more than 1000 deaths in Australia, and costs the health care system over $700 million each year.

14 Sep 2004

Researchers discover that DNA fragments destroy melanoma cells

Researchers at Boston University School of Medicine have discovered that small DNA fragments or oligonucleotides that resemble the telomere (chromosome end), also called T-oligos, can cause human melanoma cells to undergo extensive apoptosis (cell death), while surviving melanoma cells become more differentiated and therefore less aggressive.

1 Sep 2004

PET is a more accurate way to diagnose recurrent melanoma than the present, standard procedures

A new study using positron emission tomography (PET) determined PET is a more accurate way to diagnose recurrent melanoma than the present, standard procedures.

5 Aug 2004

New approach to cancer vaccines may eradicate skin cancer tumors

Mayo Clinic and British researchers have developed a new approach to cancer vaccines that purposely kills healthy skin cells to target the immune system against tumors. The new approach has eradicated skin cancer tumors in mice.

2 Aug 2004

Skin Cancer News and Research

Latest Skin Cancer News and Research

Abbott's investigational anti-interleukin-12 fully human monoclonal antibody in Crohn's disease study

New study to determine whether natural tomato oil may reverse or delay progression of prostate cancer

Obesity could more than double an older woman's risk of acute myelogenous leukemia

Link between immune protein and longer survival in melanoma patients

STAT3 protein could lead to new ways to prevent skin cancer

Common antibacterial and antifungal ingredient used in tooth paste may protect against skin cancer

Cyclopamine, derived from the corn lily may treat and prevent basal cell carcinoma

Melanin is not only good for you, it also can be bad

Nanotechnology company pSivida granted European patent

Wound healers cause skin disease

Half of all Australians still believe a tan is healthy

Researchers are studying a vaccine that, in the future, could be the first to treat advanced malignant melanoma

Skin cancer rates concern Australian health experts

Prostate cancer treatment leads to declines in sexual and urinary function

University of Arizona spin-off investigates DNA damage to human skin

Certain cancers might one day be cured without the use of toxic chemotherapy and radiation

Shade structures are not built effectively

Researchers discover that DNA fragments destroy melanoma cells

PET is a more accurate way to diagnose recurrent melanoma than the present, standard procedures

New approach to cancer vaccines may eradicate skin cancer tumors

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Skin Cancer News and Research

Latest Skin Cancer News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in